The DSM-5: A Vehicle For High-Profit Patent Extensions? Gregg Fields & Lisa Cosgrove | Labcast by Harvard University published on 2014/01/30 18:26:00 +0000 The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders affects drugs with sales in the billions of dollars. In research supported by the Edmond J. Safra Center for Ethics, Lisa Cosgrove of UMass-Boston investigated financial ties between DSM panel members and the pharmaceutical companies that have a vested interest in finding new indications for their blockbuster drugs. In this podcast, she tells journalist Gregg Fields what she found, what it means—and why we all should care. "Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5," Psychotherapy and Psychosomatics: http://www.karger.com/Article/FullText/357499.